Bijan Nejadnik, MD

Articles by Bijan Nejadnik, MD

Stem Cell Therapy Studies in TBI and Stroke: Bijan Nejadnik, MD

February 7th 2021

The chief medical officer at SanBio discussed how the investigational agent SB623 is being studied in TBI and stroke, with future planned studies in Alzheimer disease.

Restoring Function in TBI with Stem Cell Therapy: Bijan Nejadnik, MD

ByBijan Nejadnik, MD

January 24th 2021

The chief medical officer at SanBio discussed how the investigational agent SB623 can fill the void of disease-modifying therapies for TBI.

Latest Updated Articles

Restoring Function in TBI with Stem Cell Therapy: Bijan Nejadnik, MD
Published: January 24th 2021 | Updated:
Stem Cell Therapy Studies in TBI and Stroke: Bijan Nejadnik, MD
Published: February 7th 2021 | Updated:

Bijan Nejadnik, MD

Articles by Bijan Nejadnik, MD

Stem Cell Therapy Studies in TBI and Stroke: Bijan Nejadnik, MD

Restoring Function in TBI with Stem Cell Therapy: Bijan Nejadnik, MD

Latest Updated Articles

Trending on CGTlive®

Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial

Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025

Guess the Therapy Answer October 16, 2025

Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years

Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation